Future Medicine India - December 2021
Future Medicine India - December 2021
Magzter Gold ile Sınırsız Kullan
Tek bir abonelikle Future Medicine India ile 9,000 + diğer dergileri ve gazeteleri okuyun kataloğu görüntüle
1 ay $9.99
1 Yıl$99.99
$8/ay
Sadece abone ol Future Medicine India
bu sayıyı satın al $3.99
Subscription plans are currently unavailable for this magazine. If you are a Magzter GOLD user, you can read all the back issues with your subscription. If you are not a Magzter GOLD user, you can purchase the back issues and read them.
Bu konuda
RESURGENCE-- THE OMICRON WAY
With vaccination offering limited help and lockdowns impossible , India has few options in its fight against Omicron
EXPERTS PREDICT THIRD WAVE IN INDIA WITH MORE THAN A LAKH DAILY CASES IN FEBRUARY
The active cases have come down as compared July leveld, the threat of new variants is looming large.
1 min
AstraZeneca's new covid drug AZD7442 shows 83% prevention and 88% treatment efficacy
AstraZeneca, which announced the latest data from Phase III trials of its new Covid-19 drug -- AZD7442 -- said both the prevention and outpatient treatment studies showed robust efficacy from a onetime intramuscular (IM) dose of the long-acting antibody combination.
1 min
DIABETES, AT CLOSE TO 91 MILLION CASES, ACCOUNTS FOR 25% OF ALL NCDS IN INDIA
The disease incidence, which increases very rapidly in individuals above 35 years of age, accounts for 12.8 million DALYs, 6.7 million YLDs
4 mins
Early Reports On Omicron Encouraging: Anthony Fauci
Even as the Omicron variant of coronavirus is spreading across the world quickly, early reports suggest that it may cause less severe disease than the Delta variant, says Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, US.
8 mins
Importance Of Adhering To Covid Appropriate Behaviour
As the efficacy of existing vaccines has been proven to be inadequate against Omicron, our only hope from the jab is to reduce the severity of the disease, highlighting the importance of adhering to covid appropriate behaviour
10+ mins
END INEQUALITIES TO MEET THE TARGET OF ENDING AIDS
Forty years after the first AIDS case was reported, and 35 years since the first case in India, HIV still threatens us. Today, the world is off track from delivering on the shared commitment to end AIDS by 2030.
4 mins
UK approves sotrovimab as new covid treatment for high risk adults
The Medicines and Healthcare Products Regulatory Agency (MHRA), the drug regulator of the UK, has approved sotrovimab, branded as Xevudy, a new biological drug to fight Covid-19. The drug was found effective to reduce the likelihood of hospital admission and death by about 79 percent in high-risk adults.
3 mins
CONVENTIONAL LINEN IS ONE OF THE BIGGEST CULPRITS IN HOSPITAL ACQUIRED AS WELL AS SURGICAL SITE INFECTIONS
The ‘green colour’ linen is synonymous with hospitals, as it has been in use for centuries in hospitals world over, especially the conventional healthcare settings. But how many, even in the medical community, are really conscious about the responsibility for and the critical role of this piece of medical accessory in ensuring patient safety? Evidence from most hospitals in India indicates that not many are aware of the standards, and even if they are, not many bother with them. Again, going by real world experience, there exists another paradox. Though the actual cost of the repeated use of the linen is higher than the cost of single-use disposables (recommended in modernday care), it is still being used in a large majority of hospitals and clinics in India — because it is the convention. Therefore, transformation hesitance is more of a mindset issue rather than ignorance or economics. Most in the industry also oppose quality regulations in the country. In a market where hundreds of textile weavers and cloth merchants turned medical mask and accessory manufacturers overnight during the Covid pandemic, the market situation serves the unscrupulous minds who only eye the profits. However, there are a handful of local companies, besides the large organised players, who stick to quality products in this predominently price conscious market due to internal SOPs or pure commitment. For JAMES GEORGE, Founder and Managing Director at Kochi-based Careon Healthcare Solutions, it is more of a personal commitment. In a freewheeling interview with Editor CH UNNIKRISHNAN, George says that the primary reason behind the rise of unscrupulous players in the medical disposables market is lack of awareness among the users and the patients. Edited excerpts:
5 mins
Air Pollution Reduces 8 Years Of Life Expectancy In India
India registers 18 percent of deaths annually due to air pollution and related diseases, while nationwide socioeconomic inequalities persist in asthma diagnosis across India
10+ mins
VACCINES IN YOUR POCKET
DR. SAUMYA SWAMINATHAN Cheif Scientist, World Health Organisation
1 min
Future Medicine India Magazine Description:
Yayıncı: NextGen Science Media Pvt Ltd
kategori: Health
Dil: English
Sıklık: Monthly
Future Medicine is a monthly medical science and news magazine, specially designed and developed for the medical fraternity of India. It empowers clinicians with the knowledge of latest breakthroughs in science, provides prompt updates on emerging medical and industry trends. It imparts timely news, views and analysis of tomorrow’s science, along with a discussion forum of medical science experts, who can predict and influence the future of healthcare.
Future Medicine’s multi-format approach allows new-age medical and life sciences professionals to browse through topics that most appeal to them, put forth in an easy-to-understand and interesting manner. The primary focus is on bridging the gap between medical researchers and clinicians. Future Medicine ushers a refreshing change in the manner of scientific information access within the field of medical science.
İstediğin Zaman İptal Et [ Taahhüt yok ]
Sadece Dijital
